FreeTCCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 30, 2014Vol.37 No.06
FreeTCCL Archive Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse May 29, 2014Vol.37 No.05
FreeTCCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival May 01, 2014Vol.37 No.04
FreeTCCL Archive Study: Robotic-Assisted Surgery Offers Better Cancer Control March 31, 2014Vol.37 No.03
FreeTCCL Archive Five Years after Proton Therapy, 75-99% of Men Live Prostate Cancer Cancer-Free, Study Says February 27, 2014Vol.37 No.02
FreeTCCL Archive Study: Gene Assay Can Provide Valid Prognostic Information February 03, 2014Vol.37 No.01
